Samuel McKay

Bio

Prior to co-founding Axiom in 1994, Mr. McKay had an extensive investment career as a securities analyst, portfolio manager and venture capitalist. In the 1970s, he managed the CIGNA Insurance Co. venture capital fund until leaving to start his own business in 1981. He also founded and managed a special equity fund for early stage public companies while at CIGNA Since then, Mr. McKay has managed two successful venture capital partnerships: Connecticut Seed Ventures (1987-1997) and Ventech Partners (1982-1992). Mr. McKay also founded and was Chief Executive Officer of a successful venture backed company, Targetech, Inc., and had an earlier career in high energy laser physics research. He has been a Director of a number of companies, among them Aironet (Cisco), Anika Therapeutics, CoStar Corp., Aeronca, Inc., Exelan (Novell), HHB Softron (Cadnetics), Open Solutions, Scientific Communications. He was lead investor for New Enterprise Associates, lead investor, Special Limited Partner and chaired the Valuation Committee for Oak Investment Partners Mr. McKay currently serves on the Boards of several Axiom portfolio companies including Anika Therapeutics, Open Solutions, Inc. His areas of expertise are both technology and healthcare Mr. McKay has a B.A. in physics and an M.B.A. in finance